Explore All 401 Growth Capital Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | October 1, 2017 |
| Target | Ace Pharmaceuticals |
| Sector | Life Science |
| Investor(s) |
Quadrum Capital
Gilde Healthcare Rivean Capital |
| Deal Type | Growth Capital |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2012 |
| PE ASSETS | 920M EUR |
| Size | Large |
| Type | Sector Agnostic |
Quadrum Capital is a private investment firm focused on profitable mid-sized Western European companies with at least €2 million of EBITDA. Sectors of interest include IT, packaging, healthcare services, and human capital. Quadrum Capital was formed in 2012 and is headquartered in Almelo, Netherlands.
| Deal Context for Investor | # |
|---|---|
| Overall | 5 of 35 |
| Sector: Life Science | 1 of 1 |
| Type: Growth Capital | 2 of 11 |
| Country: Netherlands | 4 of 32 |
| Year: 2017 | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-12-01 |
Improven
Utrecht, Netherlands Improven is a combination of Improve , Prove and Proven - optimizing customer performance, with demonstrable results and with a proven approach. Together with their customers, they improve performance by designing, managing and improving processes and information provision. Improven is based in Utrecht, Netherlands. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-12-29 |
Conflux
Nieuwegein, Netherlands Conflux is a network of niche IT companies with expertise in the data, software and cloud domain. Conflux is based in Nieuwegein, Netherlands. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1982 |
| PE ASSETS | 2.6B EUR |
| Size | Large |
| Type | Sector Focused |
Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 1982 and is headquartered in Utrecht, Netherlands.
| Deal Context for Investor | # |
|---|---|
| Overall | 39 of 56 |
| Sector: Life Science | 20 of 26 |
| Type: Growth Capital | 6 of 7 |
| Country: Netherlands | 14 of 21 |
| Year: 2017 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-08-29 |
ViroClinics
Rotterdam, Netherlands ViroClinics is a virology contract research organization, serving the biopharmaceutical community with a broad range of preclinical, clinical diagnostic, assay development and clinical trial logistics services. Operating at a global level, Viroclinics is the preferred virology testing laboratory for several of the top-10 biopharmaceutical companies. Viroclinics’ extensive experience with clinical and preclinical studies for viruses, including its specialty in respiratory viruses, puts the company at the forefront in supporting the development of vaccines, antibodies and antiviral compounds targeting viral infectious diseases. ViroClinics was founded in 2001 and is based in Rotterdam, Netherlands. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-30 |
FIRE1
Dublin, Ireland FIRE1 focuses on developing a novel remote monitoring device to improve outcomes for patients suffering from an increased risk of heart failure. Early detection enables a timely intervention and adjustment of pharmacotherapy, thus avoiding hospitalisation, improving quality of life and lowering health care costs. FIRE1 was founded in 2013 and is based in Dublin, Ireland. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1982 |
| PE ASSETS | 5.0B EUR |
| Size | Mega |
| Type | Sector Agnostic |
Gilde Buy Out Partners (GBO) is unit of Gilde Investment Management, a Dutch private equity group. Gilde Buy Out Partners (GBO) targets investments in larger businesses valued from €75 and €600 million with at least €8 million in cash flow. Broad sectors of interest include services, consumer goods, manufacturing, and industrial products. GBO looks for investments across Western Europe, with an emphasis on opportunities in Belgium, The Netherlands, Luxembourg, France, Germany, Switzerland and Austria. Gilde was formed in 1982 and has offices in Utrecht, Paris, Brussels, and Zurich.
| Deal Context for Investor | # |
|---|---|
| Overall | 48 of 78 |
| Sector: Life Science | 3 of 3 |
| Type: Growth Capital | 1 of 4 |
| Country: Netherlands | 26 of 43 |
| Year: 2017 | 4 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-07-26 |
Storio group
Amsterdam, Netherlands Storio group is a consumer photo products company that offers personalized products such as photo books, wall decor, calendars, cards, prints, and gifts, enabling customers to create and preserve memories using its photo creation technology and e-commerce platforms. The Company operates across multiple European markets through a portfolio of local brands and combines online ordering with manufacturing and printing capabilities to serve its retail customer base. Storio group was founded in 2003 and is based in Amsterdam, Netherlands. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-12-01 |
ZND
Rotherham, United Kingdom ZND is a manufacturer of temporary fences (panels and barriers) for construction and event markets. The Company runs a highly efficient and fully automated production process and sells to distributors and rental companies around the globe. ZND UK was founded in 1965 and is based in Rotherham, United Kingdom. |
Buy | - |
